Eva van Rikxoort, PhD. | Founder and CEO

Eva van Rikxoort, PhD. | Founder and CEO

Science should be used for

the benefit of all people

At Thirona we go far beyond building algorithms that improve clinical workflow efficiency for the most common pathologies. We use AI technology to also tackle rare diseases and complex conditions. We apply AI to capture the knowledge that helps speed up scientific progress in healthcare. We believe that only by collaborating with partners across the value chain we can make science reach the clinics faster and achieve a truly sustainable impact.

About Thirona Retina

Thirona Retina BV is a spin-out company of a Dutch based Thirona BV, fast-growing global company specializing in the field of AI assisted medical image analysis. Since its inception in 2014, Thirona has grown from a science-based startup to a market leader in AI-powered image analysis. With a market leading AI platform and proven reputation in the lung diseases domain, Thirona has a successful track record in developing solutions for eye care. Following recent market expansion of RetCAD™, the flagship AI solution for eye disease screening, the company decided to spin out her Retina division. While building further on the scientific heritage and technology expertise of Thirona, Thirona Retina focuses entirely on eye diseases.

The Class IIa European MDR CE certified RetCAD™ software uses state-of-the-art deep learning and computer vision technology to provide precisely quantified analysis of eye images, supported by internationally standardized clinical evidence. The software assists eye care specialists in early diagnosis and grading of vision threatening diseases, such as Age-related Macular Degeneration (AMD), Diabetic Retinopathy (DR) and Glaucoma. RetCAD™ is available to clinical and optical markets through integrations with all major fundus camera vendors (Topcon, Tomey, Nidek, Canon, iCare) and supports multiple national screening programs in UK, and Europe.